| Treatments | I: Anterior uveitis (42) | II: Intermediate uveitis (16) | III: Posterior uveitis (7) | IV: Panuveitis (9) |
|---|---|---|---|---|
| High dose systemic steroid | 45% (19) | 80% (12) | 71% (5) | 100% (9) |
| Synth DMARDs | 66% (27) (MTX-26, AZA-2) | 60% (9) (MTX, AZA) | 71% (5) (MTX, AZA) | 78% (7) (MTX, AZA, COL) |
| SynthDMARDs + Biologics | 34% (14) (IFX-4, ADA-10) | 33% (5) (IFX-1, TCZ-1, IFN-4) | 43% (3) (IFX-2, IFN-1) | 33% (3) (IFX-3) |
| Surgery | 18% (7) (cataracts – 5, glaucoma – 1, keratopathy – 1) | 20% (3) (cataracts – 3, vitrectomy – 1) | 0 | 63% (5) (cataracts – 2, glaucoma – 1, vitrectomy – 1, antiangio. inj.– 1) |